Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001096906-12-002459
Filing Date
2012-09-28
Accepted
2012-09-28 12:54:48
Documents
5
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. 10KA1 2011-06-30 aoxing10ka1.htm 10-K/A 849974
2 CERTIFICATION aoxing10ka1exh311.htm EX-31.1 12775
3 CERTIFICATION aoxing10ka1exh312.htm EX-31.2 12710
4 CERTIFICATION aoxing10ka1exh321.htm EX-32.1 6870
5 CERTIFICATION aoxing10ka1exh322.htm EX-32.2 6963
  Complete submission text file 0001096906-12-002459.txt   890667
Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-32674 | Film No.: 121115622
SIC: 2834 Pharmaceutical Preparations